Acetylsalicylic Acid and the Primary Prevention of Cardiovascular Disease

Prepared by Geoffrey Anderson, MD, PhD, Senior Scientist, Institute for Clinical Evaluation and Sciences in Ontario (ICES) and Associate Porfessor, Department of Health Administration, University of Toronto, Ontario

1. Antiplatelet Trialists' Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ 1988; 296: 320-331

2. Hennekens CH, Buring JE, Sandercock P, et al: Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989; 80: 749-756

3. Hennekens CH, Buring JE: Aspirin and cardiovascular disease. Bull NY Acad Med 1989; 65: 57-68

4. Peto R, Gray R, Collins R, et al: Randomised trial of prophylactic daily aspirin in British male doctors. BMJ 1988; 296: 313-316

5. Steering Committee of the Physicians' Health Study Research Group: Preliminary report: findings from the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1988; 318: 262-264

6. Steering Committee of the Physicians' Health Study Research Group: Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989; 321: 129-135

7. Manson JE, Grobbee DE, Stampfer MJ, et al: Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. Am J Med 1990; 89: 772-776

8. Manson JE, Stampfer MJ, Colditz GA, et al: A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991 266(4): 521-527

9. Sempos CT, Cooper RS: The Physicians' Health Study: aspirin for the primary prevention of myocardial infarction [C]. N Engl J Med 1988; 318: 924-925

10. Hennekens CH, Peto R, Hutcheson GB, et al: An overview of the British and American aspirin studies [C] N Engl J Med 1988; 318: 923-924.

11. Antiplatelet Trialists' Collaboration: Collaborative overview of randomized trials of antiplatelet treatment. Part 1: prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994; 308: 81-106

12. Jonas S: The Physicians' Health Study: a neurologist's concern. Arch Neurol 1990; 47: 1352-1353

13. Canadian Task Force on the Periodic Health Examination: The periodic health examination, 1991 update: 6. Acetylsalicylic acid and the primary prevention of cardiovascular disease. Can Med Assoc J 1991; 145: 1091-1095